Sweet’s Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis.

Asami Fujii ¹, Yoko Mizutani ¹, Yuki Hattori ¹, Tomoko Takahashi ¹, Hidenori Ohnishi ², Shozo Yoshida ³, Mariko Seishima ¹ , Case Rep Dermatol. 2017 May 22;9(2):13-18.

After the first session of GMA therapy, all symptoms including the erythematous lesions and fever were completely resolved, and serum G-CSF level was reduced. Leukocyte count, neutrophil count, serum amyloid A protein, and CRP levels were restored within normal ranges by 2 weeks. Thus, GMA therapy can successfully treat a patient with recurrent Sweet’s syndrome, potentially related to the restoration of elevated serum G-CSF levels.

https://pubmed.ncbi.nlm.nih.gov/28611630/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465522/pdf/cde-0009-0013.pdf